Tilray Brands (TLRY) Other Non Operating Income (2017 - 2026)
Tilray Brands' (TLRY) quarterly Other Non Operating Income came in at -$7.2 million in Q2 2026, down 384.13% YoY from $2.5 million in Q2 2025, and down 157.56% on a QoQ basis from $12.5 million in Q1 2026.
Tilray Brands (TLRY) Other Non Operating Income (2017 - 2026) Analysis & Trends
Tilray Brands (TLRY) has 10 years of Other Non Operating Income data on file, last reported at -$7.2 million in Q2 2026.
- Quarterly Other Non Operating Income fell 384.13% year-over-year to -$7.2 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $1.9 million (up 104.54% YoY) and the FY2026 annual result came in at $1.9 million, up 104.54% from the prior year.
- Other Non Operating Income fell to -$7.2 million in Q2 2026, from $12.5 million in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $71.0 million in Q1 2022 to a low of -$40.3 million in Q2 2023.
- A 5-year average of -$2.2 million and a median of -$2.0 million in 2023 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2022 — Other Non Operating Income surged 1928.96% — and 2024, when it plunged 3200.49%.
- Tracing TLRY's Other Non Operating Income over 5 years: stood at -$6.1 million in 2022, then soared by 83.21% to -$1.0 million in 2023, then sank by 3200.49% to -$33.8 million in 2024, then jumped by 69.44% to -$10.3 million in 2025, then jumped by 30.5% to -$7.2 million in 2026.
- The last three Other Non Operating Income figures came in at -$7.2 million (Q2 2026), $12.5 million (Q1 2026), and -$10.3 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.86 Bn | 42.90 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.54 Bn | 2.15 Bn |
| 3 | Zoetis | 31.46 Bn | 29.79 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.57 Bn | 22.77 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.71 Bn | 11.18 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | Tilray Brands | 516.67 Mn | 282.03 Mn | 90.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -7.18 Mn |
| Feb 28, 2026 | 12.47 Mn |
| Nov 30, 2025 | -10.33 Mn |
| Aug 31, 2025 | 6.93 Mn |
| May 31, 2025 | 2.53 Mn |
| Feb 28, 2025 | -22.29 Mn |
| Nov 30, 2024 | -33.80 Mn |
| Aug 31, 2024 | 11.88 Mn |
| May 31, 2024 | 3.77 Mn |
| Feb 29, 2024 | -8.25 Mn |
| Nov 30, 2023 | -1.02 Mn |
| May 31, 2023 | -40.29 Mn |
| Feb 28, 2023 | -1.96 Mn |
| Nov 30, 2022 | -6.10 Mn |
| Aug 31, 2022 | -25.57 Mn |
| May 31, 2022 | 11.34 Mn |
| Feb 28, 2022 | 71.04 Mn |
| Nov 30, 2021 | 65.60 Mn |
| Aug 31, 2021 | -5.72 Mn |
| May 31, 2021 | -161.25 Mn |